Literature DB >> 9815135

Dietary lipids regulate beta-oxidation enzyme gene expression in the developing rat kidney.

F Ouali1, F Djouadi, C Merlet-Bénichou, J Bastin.   

Abstract

This study examines the ability of dietary lipids to regulate gene expression of mitochondrial and peroxisomal fatty acid beta-oxidation enzymes in the kidney cortex and medulla of 3-wk-old rats and evaluates the role of glucagon or of the alpha-isoform of peroxisome proliferator-activated receptor (PPARalpha) in mediating beta-oxidation enzyme gene regulation in the immature kidney. The long-chain (LCAD) and medium-chain acyl-CoA dehydrogenases (MCAD) and acyl-CoA oxidase (ACO) mRNA levels were found coordinately upregulated in renal cortex, but not in medulla, of pups weaned on a high-fat diet from day 16 to 21. Further results establish that switching pups from a low- to a high-fat diet for only 1 day was sufficient to induce large increases in cortical LCAD, MCAD, and ACO mRNA levels, and gavage experiments show that this upregulation of beta-oxidation gene expression is initiated within 6 h following lipid ingestion. Treatment of pups with clofibrate, a PPARalpha agonist, demonstrated that PPARalpha can mediate regulation of cortical beta-oxidation enzyme gene expression, whereas glucagon was found ineffective. Thus dietary lipids physiologically regulate gene expression of mitochondrial and peroxisomal beta-oxidation enzymes in the renal cortex of suckling pups, and this might involve PPARalpha-mediated mechanisms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9815135     DOI: 10.1152/ajprenal.1998.275.5.F777

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  17 in total

1.  Effects of maternal hypercholesterolemia on pregnancy and development of offspring.

Authors:  Sônia Maria Alves De Assis; Antonio Carlos Seguro; Claudia Maria Barros Helou
Journal:  Pediatr Nephrol       Date:  2003-03-21       Impact factor: 3.714

Review 2.  Nuclear receptors in renal disease.

Authors:  Moshe Levi
Journal:  Biochim Biophys Acta       Date:  2011-04-14

Review 3.  Nuclear hormone receptors in diabetic nephropathy.

Authors:  Xiaoxin X Wang; Tao Jiang; Moshe Levi
Journal:  Nat Rev Nephrol       Date:  2010-04-27       Impact factor: 28.314

4.  Proximal tubule PPARα attenuates renal fibrosis and inflammation caused by unilateral ureteral obstruction.

Authors:  Shenyang Li; Nithya Mariappan; Judit Megyesi; Brian Shank; Krishnaswamy Kannan; Sue Theus; Peter M Price; Jeremy S Duffield; Didier Portilla
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-26

5.  Long-term n-3 FA deficiency modifies peroxisome proliferator-activated receptor beta mRNA abundance in rat ocular tissues.

Authors:  Cecilia V Rojas; Rebecca S Greiner; Lidia C Fuenzalida; Jessica I Martinez; Norman Salem; Ricardo Uauy
Journal:  Lipids       Date:  2002-04       Impact factor: 1.880

6.  Role of PPARα and Its Agonist in Renal Diseases.

Authors:  Ching-Feng Cheng; Hsi-Hsien Chen; Heng Lin
Journal:  PPAR Res       Date:  2010-11-08       Impact factor: 4.964

7.  Protein profiling of mouse livers with peroxisome proliferator-activated receptor alpha activation.

Authors:  Ruiyin Chu; Hanjo Lim; Laura Brumfield; Hong Liu; Chris Herring; Peter Ulintz; Janardan K Reddy; Matthew Davison
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

8.  The renoprotective actions of peroxisome proliferator-activated receptors agonists in diabetes.

Authors:  M C Thomas; K A Jandeleit-Dahm; C Tikellis
Journal:  PPAR Res       Date:  2012-02-12       Impact factor: 4.964

9.  Peroxisome proliferator-activated receptors in diabetic nephropathy.

Authors:  Shinji Kume; Takashi Uzu; Keiji Isshiki; Daisuke Koya
Journal:  PPAR Res       Date:  2009-03-04       Impact factor: 4.964

10.  Oxidation of fatty acids is the source of increased mitochondrial reactive oxygen species production in kidney cortical tubules in early diabetes.

Authors:  Mariana G Rosca; Edwin J Vazquez; Qun Chen; Janos Kerner; Timothy S Kern; Charles L Hoppel
Journal:  Diabetes       Date:  2012-05-14       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.